Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain

Current Medical Research and Opinion

Volumn 31, Issue 12, 2015, Pages 2207-2218

  Arai, Tsutomu ^a   Kashimoto, Yuji ^a   Ukyo, Yoshifumi ^a   Tominaga, Yushin ^a   Imanaka, Keiichiro ^a  

^a Janssen Pharmaceutical KK   (Japan)

Author keywords

1 day patch; Chronic pain; Fentanyl; Opioid

Indexed keywords

FENTANYL; OPIATE; NARCOTIC ANALGESIC AGENT;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANALGESIA; ANXIETY DISORDER; APPLICATION SITE PRURITUS; ARTICLE; ASPIRATION PNEUMONIA; ASTHENIA; BREAKTHROUGH PAIN; BRIEF PAIN INVENTORY; CHRONIC BRONCHITIS; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HALLUCINATION; HUMAN; INFECTION; INSOMNIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; NUTRITIONAL DISORDER; OSTEOARTHRITIS; PANCREAS CARCINOMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 3 CLINICAL TRIAL; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SHORT FORM 36; SOMNOLENCE; STOMACH ULCER; URINE RETENTION; VISUAL ANALOG SCALE; VOMITING; WITHDRAWAL SYNDROME; CLINICAL TRIAL; JAPAN; MIDDLE AGED; PAIN MEASUREMENT; PHASE 2 CLINICAL TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC PAIN; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; JAPAN; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT;

EID: 84955703294     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1092127     Document Type: Article

References (13)

1. Suzuki T. Opioid therapy for non-cancer chronic pain. Treatment with weak opioid and codeine (in Japanese). J Pain Clin Med 2003;3:199-203
2. Knop C, Oeser M, Bastian L, et al. Development and validation of the Visual Analogue Scale (VAS) Spine Score. Unfallchirurg 2001;104:488-97
3. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38
4. McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66
5. Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35:253-9
6. Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin 2007;23:117-28
7. Hale ME, Ahdieh H, Ma T, et al. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week randomized double-blind placebocontrolled study. J Pain 2007;8:175-84
8. Miyazaki T, Hanaoka K, Namiki A, et al. Clinical trial of Durotep MT patch in patients with chronic non-cancer pain I-4 weeks and long-term 52 weeks study (in Japanese). J New Rem Clin 2010;59:157-80
9. Miyazaki T, Hanaoka K, Ogawa S, et al. Clinical trial of Durotep MT patch in patients with chronic non-cancer pain II-4 weeks study with the pain control achievement rate as the primary endpoint (in Japanese). J New Rem Clin 2010;59:181-200
10. Hanaoka K, Yoshimura T, Tomioka T, Sakata H. Clinical study of one-day fentanyl patch in patients with cancer pain-evaluation of the efficacy and safety in relation to treatment switch from opioid analgesic therapy (in Japanese). Masui 2011;60:147-56
11. Hanaoka K, Yoshimura T, Tomioka T, Sakata H. Double-blind parallel-group dose-titration study comparing a fentanyl-containing patch formulated for 1-day application for the treatment of cancer pain with Durotep MT patch (in Japanese). Masui 2011;60:157-67
12. Imanaka K, Yoshimura T, Shikinami K, et al. A phase 3 study of JNS020QD (fentanyl transdermal matrix 1-day system) in patients with chronic noncancer pain: efficacy and safety at switching from opioid analgesics in long-term use (in Japanese). Pain Clinic 2014;35:781-90
13. Lemmens HJ, Wada DR, Munera C, et al. Enriched analgesic efficacy studies: an assessment by clinical trial simulation. Contemp Clin Trials 2006;27:165-73